In recent years, several case reports have been published suggesting an association between the use of 5-aminosalicylic acid (5-ASA) in patients with inflammatory bowel disease (IBD) and the development of chronic tubulo-interstitial nephritis. Apart from lesions associated to 5-ASA treatment, however, it is clear that IBD itself may also induce renal impairment, albeit the frequency is unknown. During 1 year, all IBD patients seen at the outpatient clinic of 27 European centres of gastro-enterology were registered and screened for renal impairment controlling for a possible association with 5-ASA therapy. Patients were questioned about their medical and drug history and their IBD disease activity. Renal screening (calculated creatinine cle...
Background: Although the iatrogenic risk of kidney failure is infrequent with treatment for inflamma...
Background & AimsNephrotoxicity is a rare idiosyncratic reaction to 5-aminosalicylate (5-ASA) therap...
Inflammatory bowel disease and its various treatments may affect the kidney in several ways. Recentl...
Background: In recent years, several case reports have been published suggesting an association betw...
BackgroundAcute interstitial nephritis (AIN) is an important cause of kidney injury accounting for u...
International audienceBackground and aim: 5-Aminosalicylates (ASA) are widely used in inflammatory b...
BACKGROUND and AIMS: This study was performed to quantify the risk of renal disease in patients usin...
Introduction: drugs containing 5-ASA (aminosalicylates) are widely used in the management of inflamm...
BACKGROUND: Case reports concerning irreversible renal failure caused by 5-aminosalicylates (5-ASA) ...
Renal manifestations and complications are not rare in patients with inflammatory bowel disease (IBD...
Renal and urinary tract complications related to inflammatory bowel disease (IBD) have been relative...
Conservative management of inflammatory bowel disease (IBD) is based on a combination of drugs, incl...
Background and Aims: Nephrotoxicity is a rare idiosyncratic reaction to 5-aminosalicylate (5-ASA) th...
Background and Aims: Nephrotoxicity is a rare idiosyncratic reaction to 5-aminosalicylate (5-ASA) th...
Background: Although the iatrogenic risk of kidney failure is infrequent with treatment for inflamma...
Background & AimsNephrotoxicity is a rare idiosyncratic reaction to 5-aminosalicylate (5-ASA) therap...
Inflammatory bowel disease and its various treatments may affect the kidney in several ways. Recentl...
Background: In recent years, several case reports have been published suggesting an association betw...
BackgroundAcute interstitial nephritis (AIN) is an important cause of kidney injury accounting for u...
International audienceBackground and aim: 5-Aminosalicylates (ASA) are widely used in inflammatory b...
BACKGROUND and AIMS: This study was performed to quantify the risk of renal disease in patients usin...
Introduction: drugs containing 5-ASA (aminosalicylates) are widely used in the management of inflamm...
BACKGROUND: Case reports concerning irreversible renal failure caused by 5-aminosalicylates (5-ASA) ...
Renal manifestations and complications are not rare in patients with inflammatory bowel disease (IBD...
Renal and urinary tract complications related to inflammatory bowel disease (IBD) have been relative...
Conservative management of inflammatory bowel disease (IBD) is based on a combination of drugs, incl...
Background and Aims: Nephrotoxicity is a rare idiosyncratic reaction to 5-aminosalicylate (5-ASA) th...
Background and Aims: Nephrotoxicity is a rare idiosyncratic reaction to 5-aminosalicylate (5-ASA) th...
Background: Although the iatrogenic risk of kidney failure is infrequent with treatment for inflamma...
Background & AimsNephrotoxicity is a rare idiosyncratic reaction to 5-aminosalicylate (5-ASA) therap...
Inflammatory bowel disease and its various treatments may affect the kidney in several ways. Recentl...